JP2022549276A5 - - Google Patents
Info
- Publication number
- JP2022549276A5 JP2022549276A5 JP2022518285A JP2022518285A JP2022549276A5 JP 2022549276 A5 JP2022549276 A5 JP 2022549276A5 JP 2022518285 A JP2022518285 A JP 2022518285A JP 2022518285 A JP2022518285 A JP 2022518285A JP 2022549276 A5 JP2022549276 A5 JP 2022549276A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025118407A JP2025182218A (ja) | 2019-09-19 | 2025-07-14 | Ｉｌ－１５／ｉｌ－１５ｒａに基づくヘテロ二量体タンパク質複合体を含む、イムノサイトカイン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2019129569A RU2753282C2 (ru) | 2019-09-19 | 2019-09-19 | ИММУНОЦИТОКИН, ВКЛЮЧАЮЩИЙ ГЕТЕРОДИМЕРНЫЙ БЕЛКОВЫЙ КОМПЛЕКС НА ОСНОВЕ IL-15/IL-15Rα, И ЕГО ПРИМЕНЕНИЕ |
| RU2019129569 | 2019-09-19 | ||
| PCT/RU2020/050233 WO2021054867A1 (ru) | 2019-09-19 | 2020-09-20 | Иммуноцитокин, включающий гетеро димерный белковый комплекс на основе il-15 и il-15rα |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025118407A Division JP2025182218A (ja) | 2019-09-19 | 2025-07-14 | Ｉｌ－１５／ｉｌ－１５ｒａに基づくヘテロ二量体タンパク質複合体を含む、イムノサイトカイン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022549276A JP2022549276A (ja) | 2022-11-24 |
| JP2022549276A5 true JP2022549276A5 (https=) | 2023-09-28 |
| JPWO2021054867A5 JPWO2021054867A5 (https=) | 2023-09-28 |
Family
ID=74873995
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022518285A Pending JP2022549276A (ja) | 2019-09-19 | 2020-09-20 | Ｉｌ－１５／ｉｌ－１５ｒａに基づくヘテロ二量体タンパク質複合体を含む、イムノサイトカイン |
| JP2025118407A Pending JP2025182218A (ja) | 2019-09-19 | 2025-07-14 | Ｉｌ－１５／ｉｌ－１５ｒａに基づくヘテロ二量体タンパク質複合体を含む、イムノサイトカイン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025118407A Pending JP2025182218A (ja) | 2019-09-19 | 2025-07-14 | Ｉｌ－１５／ｉｌ－１５ｒａに基づくヘテロ二量体タンパク質複合体を含む、イムノサイトカイン |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20230011234A1 (https=) |
| EP (1) | EP4032539A4 (https=) |
| JP (2) | JP2022549276A (https=) |
| KR (1) | KR20220145323A (https=) |
| CN (1) | CN115297885A (https=) |
| AR (1) | AR120011A1 (https=) |
| AU (1) | AU2020351560A1 (https=) |
| BR (1) | BR112022005173A2 (https=) |
| CA (1) | CA3151780A1 (https=) |
| CO (1) | CO2022003156A2 (https=) |
| JO (1) | JOP20220071A1 (https=) |
| MA (1) | MA56286B1 (https=) |
| MX (1) | MX2022003306A (https=) |
| PE (1) | PE20220603A1 (https=) |
| PH (1) | PH12022550688A1 (https=) |
| PY (1) | PY2056649A (https=) |
| RU (1) | RU2753282C2 (https=) |
| TW (1) | TWI891660B (https=) |
| UY (1) | UY38889A (https=) |
| WO (1) | WO2021054867A1 (https=) |
| ZA (1) | ZA202203254B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120463822A (zh) | 2018-09-27 | 2025-08-12 | 西里欧发展公司 | 掩蔽型细胞因子多肽 |
| WO2022115865A2 (en) | 2020-11-25 | 2022-06-02 | Xilio Development, Inc. | Tumor-specific cleavable linkers |
| WO2023133595A2 (en) | 2022-01-10 | 2023-07-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| CN116178572B (zh) * | 2022-02-28 | 2025-12-23 | 厦门柏慈生物科技有限公司 | 构建嵌合蛋白的嵌合区域、构建方法、嵌合蛋白及其应用 |
| CN115141283A (zh) * | 2022-03-10 | 2022-10-04 | 厦门柏慈生物科技有限公司 | 一种融合蛋白、制备方法及其应用 |
| US20250222027A1 (en) | 2022-04-01 | 2025-07-10 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
| CN116854821A (zh) * | 2022-08-15 | 2023-10-10 | 海徕科(北京)生物技术有限公司 | IL-15突变体-Fc/IL-15Rα亚基-Fc异源二聚体及其用途 |
| CN121241063A (zh) * | 2023-08-04 | 2025-12-30 | 上海艾乐晞生物科技有限公司 | Sushi结构域突变体、融合蛋白、药物组合物和用途 |
| WO2025140627A1 (zh) * | 2023-12-28 | 2025-07-03 | 南通壹宸生物医药科技有限公司 | 融合抗体及其应用 |
| WO2026037415A1 (zh) * | 2024-08-16 | 2026-02-19 | 北京清辉联诺生物科技有限责任公司 | 一种IL15/IL15Rα复合物及其在细胞疗法领域的应用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4510245A (en) | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
| US4740461A (en) | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| AU584417B2 (en) | 1985-04-01 | 1989-05-25 | Lonza Group Ag | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4959455A (en) | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
| US4912040A (en) | 1986-11-14 | 1990-03-27 | Genetics Institute, Inc. | Eucaryotic expression system |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| GB8809129D0 (en) | 1988-04-18 | 1988-05-18 | Celltech Ltd | Recombinant dna methods vectors and host cells |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| ES2221065T3 (es) * | 1996-08-16 | 2004-12-16 | The President And Fellows Of Harvard College | Proteinas de fusion de clase ii del mhc, solubles, monovalentes o polivalentes, y sus usos. |
| NZ506071A (en) * | 1998-02-19 | 2003-05-30 | Harvard College | Monovalent, multivalent, and multimeric major histocompatibility complex (MHC) binding domain fusion proteins and conjugates, and uses therefore |
| WO2001046261A1 (en) * | 1999-12-23 | 2001-06-28 | Zymogenetics, Inc. | Method for treating inflammation |
| EP1777294A1 (en) | 2005-10-20 | 2007-04-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins |
| DK2160401T3 (da) * | 2007-05-11 | 2014-10-20 | Altor Bioscience Corp | Fusionsmolekyler og il-15-varianter |
| CN107880136B (zh) * | 2010-09-21 | 2021-11-12 | 阿尔托生物科学有限公司 | 多聚体il-15可溶性融合分子与其制造与使用方法 |
| EP2537933A1 (en) * | 2011-06-24 | 2012-12-26 | Institut National de la Santé et de la Recherche Médicale (INSERM) | An IL-15 and IL-15Ralpha sushi domain based immunocytokines |
| RU2687043C2 (ru) * | 2013-04-29 | 2019-05-06 | Ф. Хоффманн-Ля Рош Аг | МОДИФИЦИРОВАННЫЕ АСИММЕТРИЧНЫЕ АНТИТЕЛА, СВЯЗЫВАЮЩИЕ Fc-РЕЦЕПТОР, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
| BR112016002614B8 (pt) | 2013-08-08 | 2023-11-07 | Hopitaux Paris Assist Publique | Imunocitoquina e composição farmacêutica |
| RU2689717C2 (ru) * | 2014-01-08 | 2019-05-28 | Шанхай Хэнжуй Фармасьютикал Ко., Лтд. | Гетеродимерный белок il-15 и его применения |
| CA3151221C (en) * | 2014-06-30 | 2026-01-13 | Altor Bioscience Corporation | Il-15-based molecules and methods of use thereof |
| AU2015366795B2 (en) | 2014-12-19 | 2020-12-17 | Jiangsu Hengrui Medicine Co., Ltd. | Interleukin 15 protein complex and use thereof |
| RU2656181C1 (ru) * | 2016-07-13 | 2018-05-31 | Закрытое Акционерное Общество "Биокад" | Анти-pd-1-антитела, способ их получения и способ применения |
| CN110214147A (zh) * | 2016-10-14 | 2019-09-06 | Xencor股份有限公司 | IL15/IL15Rα异源二聚体FC-融合蛋白 |
| CN118562016A (zh) * | 2016-10-21 | 2024-08-30 | 艾尔特生物科技公司 | 基于多聚体il-15的分子 |
| CN117986384A (zh) * | 2017-03-06 | 2024-05-07 | 艾尔特生物科技公司 | 与il-12和il-18的基于il-15的融合物 |
| RU2665790C1 (ru) | 2017-04-17 | 2018-09-04 | Закрытое Акционерное Общество "Биокад" | Моноклональное антитело к pd-l1 |
| US11084863B2 (en) * | 2017-06-30 | 2021-08-10 | Xencor, Inc. | Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains |
| US20210017247A1 (en) * | 2017-07-03 | 2021-01-21 | Torque Therapeutics, Inc. | Fusion Molecules Targeting Immune Regulatory Cells and Uses Thereof |
-
2019
- 2019-09-19 RU RU2019129569A patent/RU2753282C2/ru active
-
2020
- 2020-09-18 AR ARP200102607A patent/AR120011A1/es unknown
- 2020-09-20 MA MA56286A patent/MA56286B1/fr unknown
- 2020-09-20 WO PCT/RU2020/050233 patent/WO2021054867A1/ru not_active Ceased
- 2020-09-20 CA CA3151780A patent/CA3151780A1/en active Pending
- 2020-09-20 EP EP20865705.6A patent/EP4032539A4/en active Pending
- 2020-09-20 KR KR1020227013100A patent/KR20220145323A/ko active Pending
- 2020-09-20 JP JP2022518285A patent/JP2022549276A/ja active Pending
- 2020-09-20 PE PE2022000447A patent/PE20220603A1/es unknown
- 2020-09-20 US US17/761,838 patent/US20230011234A1/en active Pending
- 2020-09-20 BR BR112022005173A patent/BR112022005173A2/pt unknown
- 2020-09-20 MX MX2022003306A patent/MX2022003306A/es unknown
- 2020-09-20 PH PH1/2022/550688A patent/PH12022550688A1/en unknown
- 2020-09-20 CN CN202080080165.8A patent/CN115297885A/zh active Pending
- 2020-09-20 AU AU2020351560A patent/AU2020351560A1/en active Pending
- 2020-09-21 TW TW109132634A patent/TWI891660B/zh active
- 2020-09-21 PY PY202002056649A patent/PY2056649A/es unknown
- 2020-09-22 UY UY0001038889A patent/UY38889A/es unknown
-
2022
- 2022-03-17 JO JOP/2022/0071A patent/JOP20220071A1/ar unknown
- 2022-03-18 ZA ZA2022/03254A patent/ZA202203254B/en unknown
- 2022-03-18 CO CONC2022/0003156A patent/CO2022003156A2/es unknown
-
2025
- 2025-07-14 JP JP2025118407A patent/JP2025182218A/ja active Pending